Skip to main content

Chlorothiazide Sodium Injection Shortage

Last Updated: April 8, 2025
Status: Current

Products Affected - Description
    • Chlorothiazide injection, American Regent, 500 mg, vial, 1 count, NDC 00517-1820-01
    • Chlorothiazide injection, Fresenius Kabi, 500 mg, vial, 1 count, NDC 63323-0658-20
    • Chlorothiazide injection, Sagent, 500 mg, vial, 1 count, NDC 25021-0305-20
Reason for the Shortage
    • American Regent did not provide a reason for the shortage.
    • Fresenius Kabi did not provide a reason for the shortage.
    • Sagent did not provide a reason for the shortage.
Available Products
    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • American Regent has chlorothiazide 500 mg vials in limited supply with weekly releases.
    • Fresenius Kabi has chlorothiazide 500 mg vials on back order and the company estimates a release date of early-May 2025.
    • Sagent has chlorothiazide 500 mg vials on back order and the company estimates a release date of April 2025.

Updated

Updated April 8, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 12, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.